| Vitality Restored Chiropractic And Wellness Center | |
|
1742 W Horizon Ridge Pkwy Ste 110 Henderson NV 89012-4833 | |
| (725) 735-6910 | |
| (725) 735-6914 |
| Full Name | Vitality Restored Chiropractic And Wellness Center |
|---|---|
| Speciality | Clinic/Center |
| Location | 1742 W Horizon Ridge Pkwy Ste 110, Henderson, Nevada |
| Authorized Official Name and Position | Brad Partridge (DOCTOR/OWNER) |
| Authorized Official Contact | 7257356910 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Vitality Restored Chiropractic And Wellness Center 1742 W Horizon Ridge Pkwy Ste 110 Henderson NV 89012-4833 Ph: (725) 735-6910 | Vitality Restored Chiropractic And Wellness Center 1742 W Horizon Ridge Pkwy Ste 110 Henderson NV 89012-4833 Ph: (725) 735-6910 |
| NPI Number | 1023665676 |
|---|---|
| Provider Enumeration Date | 08/19/2019 |
| Last Update Date | 03/10/2020 |
| Medicare PECOS PAC ID | 9739513284 |
|---|---|
| Medicare Enrollment ID | O20191217000502 |
News Archive
CeNeRx BioPharma, today reported that it has initiated a Phase II trial of its new formulation of TriRima, the company's novel antidepressant in development as monotherapy for treatment resistant depression.
TargeGen, Inc., a privately held biotechnology company focused on the development of small molecule kinase inhibitors today announced that the Company has agreed to be acquired by sanofi-aventis. Under the agreement, the ultimate purchase price will depend on the achievement of certain future milestones events and will total $560M if such milestones are fully realized. The closing of the transaction is expected to occur in the 3rd quarter of 2010.
OncoGenex Pharmaceuticals, Inc. today announced that it has priced a public offering of 3,174,602 units, with each unit consisting of one share of the Company's common stock and one-half (1/2) of one warrant, at a purchase price of $15.75 per unit for an aggreate offering amount of $50 million.
Today's headlines focus on the details of health reform that continue to emerge - including states' reactions to high risk pools and questions about the sweeping expansion of Medicaid.
NAVTEQ, the leading global provider of digital map, traffic and location data for in-vehicle, portable, wireless and enterprise solutions, today announced that the Center for Disease Control and Prevention (CDC) has selected the NAVTEQ® map data for use within its geospatial program, GRASP (Geospatial Research, Analysis, & Services Program).
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023665676 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (* (Not Available)) | Primary |
| Provider Name | Brad Partridge |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1003326588 PECOS PAC ID: 3678827128 Enrollment ID: I20191217000652 |
News Archive
CeNeRx BioPharma, today reported that it has initiated a Phase II trial of its new formulation of TriRima, the company's novel antidepressant in development as monotherapy for treatment resistant depression.
TargeGen, Inc., a privately held biotechnology company focused on the development of small molecule kinase inhibitors today announced that the Company has agreed to be acquired by sanofi-aventis. Under the agreement, the ultimate purchase price will depend on the achievement of certain future milestones events and will total $560M if such milestones are fully realized. The closing of the transaction is expected to occur in the 3rd quarter of 2010.
OncoGenex Pharmaceuticals, Inc. today announced that it has priced a public offering of 3,174,602 units, with each unit consisting of one share of the Company's common stock and one-half (1/2) of one warrant, at a purchase price of $15.75 per unit for an aggreate offering amount of $50 million.
Today's headlines focus on the details of health reform that continue to emerge - including states' reactions to high risk pools and questions about the sweeping expansion of Medicaid.
NAVTEQ, the leading global provider of digital map, traffic and location data for in-vehicle, portable, wireless and enterprise solutions, today announced that the Center for Disease Control and Prevention (CDC) has selected the NAVTEQ® map data for use within its geospatial program, GRASP (Geospatial Research, Analysis, & Services Program).
› Verified 6 days ago
| Provider Name | Nathaniel J Rossi |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1699329110 PECOS PAC ID: 5597134593 Enrollment ID: I20221214001628 |
News Archive
CeNeRx BioPharma, today reported that it has initiated a Phase II trial of its new formulation of TriRima, the company's novel antidepressant in development as monotherapy for treatment resistant depression.
TargeGen, Inc., a privately held biotechnology company focused on the development of small molecule kinase inhibitors today announced that the Company has agreed to be acquired by sanofi-aventis. Under the agreement, the ultimate purchase price will depend on the achievement of certain future milestones events and will total $560M if such milestones are fully realized. The closing of the transaction is expected to occur in the 3rd quarter of 2010.
OncoGenex Pharmaceuticals, Inc. today announced that it has priced a public offering of 3,174,602 units, with each unit consisting of one share of the Company's common stock and one-half (1/2) of one warrant, at a purchase price of $15.75 per unit for an aggreate offering amount of $50 million.
Today's headlines focus on the details of health reform that continue to emerge - including states' reactions to high risk pools and questions about the sweeping expansion of Medicaid.
NAVTEQ, the leading global provider of digital map, traffic and location data for in-vehicle, portable, wireless and enterprise solutions, today announced that the Center for Disease Control and Prevention (CDC) has selected the NAVTEQ® map data for use within its geospatial program, GRASP (Geospatial Research, Analysis, & Services Program).
› Verified 6 days ago
News Archive
CeNeRx BioPharma, today reported that it has initiated a Phase II trial of its new formulation of TriRima, the company's novel antidepressant in development as monotherapy for treatment resistant depression.
TargeGen, Inc., a privately held biotechnology company focused on the development of small molecule kinase inhibitors today announced that the Company has agreed to be acquired by sanofi-aventis. Under the agreement, the ultimate purchase price will depend on the achievement of certain future milestones events and will total $560M if such milestones are fully realized. The closing of the transaction is expected to occur in the 3rd quarter of 2010.
OncoGenex Pharmaceuticals, Inc. today announced that it has priced a public offering of 3,174,602 units, with each unit consisting of one share of the Company's common stock and one-half (1/2) of one warrant, at a purchase price of $15.75 per unit for an aggreate offering amount of $50 million.
Today's headlines focus on the details of health reform that continue to emerge - including states' reactions to high risk pools and questions about the sweeping expansion of Medicaid.
NAVTEQ, the leading global provider of digital map, traffic and location data for in-vehicle, portable, wireless and enterprise solutions, today announced that the Center for Disease Control and Prevention (CDC) has selected the NAVTEQ® map data for use within its geospatial program, GRASP (Geospatial Research, Analysis, & Services Program).
› Verified 6 days ago
Center For Occupational Health & Wellness Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9005 S Pecos Rd, Ste 2610, Henderson, NV 89074 Phone: 702-474-0472 Fax: 702-474-4012 | |
Home Visiting Doctors Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 871 Coronado Center Dr Ste 200, Henderson, NV 89052 Phone: 702-913-9380 | |
Siena Hills Primary Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2789 Sunridge Heights Pkwy, Suite 100, Henderson, NV 89052 Phone: 702-614-0850 Fax: 702-614-0798 | |
The Doc's Primary Care, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3005 W Horizon Ridge Pkwy Ste 100, Henderson, NV 89052 Phone: 702-997-7600 | |
Srinivas Vuthoori, Md, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2610 W Horizon Ridge Pkwy, Suite #103, Henderson, NV 89052 Phone: 702-407-8241 Fax: 702-492-1728 | |
Mark Day, D.o., Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 56 N Pecos Rd Ste A, Henderson, NV 89074 Phone: 702-456-9100 Fax: 702-434-7354 |